These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 2065343

  • 1. [Observation on the epidemiologic efficacy for 9 years on epidemic meningococcal polysaccharide vaccine of group A by district immunization method].
    Ma Z.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Apr; 12(2):69-71. PubMed ID: 2065343
    [Abstract] [Full Text] [Related]

  • 2. [Changes in epidemic features of epidemic cerebrospinal meningitis after vaccination with purified meningococcal polysaccharide vaccine group A in Zhengzhou].
    Wiu JJ.
    Zhonghua Yu Fang Yi Xue Za Zhi; 1993 May; 27(3):160-1. PubMed ID: 8243180
    [Abstract] [Full Text] [Related]

  • 3. [Effectiveness of an immunization campaign with group A and C meningococcal polysaccharide vaccine in controlling an outbreak of group C meningococcal disease].
    Gong J, Li CY, Dong BQ, Huang JZ, Quan Y, Lu WZ, Luo CH, Mao WC, Liao HZ, Fang JS, Cui XL, Xie GL, Wu XH, Lan RW.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):552-5. PubMed ID: 19040035
    [Abstract] [Full Text] [Related]

  • 4. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A, Batchassi E, Yakoua Y, Croisier A, Aleki A, Schlumberger M, Molina S, Sidatt M, Kaninda AV.
    Sante; 1997 Jun; 7(6):384-90. PubMed ID: 9503496
    [Abstract] [Full Text] [Related]

  • 5. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37.
    Krizova P, Musilek M.
    Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519
    [Abstract] [Full Text] [Related]

  • 6. Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines.
    Robbins JB, Schneerson R, Gotschlich EC, Mohammed I, Nasidi A, Chippaux JP, Bernardino L, Maiga MA.
    Bull World Health Organ; 2003 Nov; 81(10):745-50; discussion 751-5. PubMed ID: 14758435
    [Abstract] [Full Text] [Related]

  • 7. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.
    Peltola H, Mäkelä H, Käyhty H, Jousimies H, Herva E, Hällström K, Sivonen A, Renkonen OV, Pettay O, Karanko V, Ahvonen P, Sarna S.
    N Engl J Med; 1977 Sep 29; 297(13):686-91. PubMed ID: 408682
    [Abstract] [Full Text] [Related]

  • 8. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N, Domínguez A, Martínez A, Alvarez J, Pañella H, Godoy P, Minguell S, Camps N, Vázquez JA, Working Group on Meningococcal Disease.
    Infection; 2003 Dec 29; 31(6):392-7. PubMed ID: 14735381
    [Abstract] [Full Text] [Related]

  • 9. Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years.
    Galloway Y, Stehr-Green P, McNicholas A, O'Hallahan J.
    Int J Epidemiol; 2009 Apr 29; 38(2):413-8. PubMed ID: 18988650
    [Abstract] [Full Text] [Related]

  • 10. [Effect of 2 vaccination strategies on developments during the epidemic of meningococcal A meningitis in N'Djamena (Chad) in 1988].
    Spiegel A, Greindl Y, Lippeveld T, Decam C, Granga D, Nahor N, Bordonado JL, Sperber G, Yankalbe M, Baudon D.
    Bull World Health Organ; 1993 Apr 29; 71(3-4):311-5. PubMed ID: 8324849
    [Abstract] [Full Text] [Related]

  • 11. [Surveillance of epidemiological features for epidemic cerebrospinal meningitis in China during 1980s].
    Hu X.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1990 Dec 29; 11(6):321-4. PubMed ID: 2125858
    [Abstract] [Full Text] [Related]

  • 12. A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.
    Erwa HH, Haseeb MA, Idris AA, Lapeyssonnie L, Sanborn WR, Sippel JE.
    Bull World Health Organ; 1973 Dec 29; 49(3):301-5. PubMed ID: 4211056
    [Abstract] [Full Text] [Related]

  • 13. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
    Wu C.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec 29; 6(6):344-6. PubMed ID: 3938683
    [No Abstract] [Full Text] [Related]

  • 14. Impact of a mass immunization campaign against serogroup C meningococcus in the Province of Quebec, Canada.
    De Wals P, Dionne M, Douville-Fradet M, Boulianne N, Drapeau J, De Serres G.
    Bull World Health Organ; 1996 Dec 29; 74(4):407-11. PubMed ID: 8823963
    [Abstract] [Full Text] [Related]

  • 15. [Application of SP-RIA in the antibody surveillance and serologic diagnosis of epidemic cerebrospinal meningitis].
    Chen X.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Dec 29; 14(6):366-70. PubMed ID: 8156584
    [Abstract] [Full Text] [Related]

  • 16. [Survey on efficacy of inoculating purified polysaccharide vaccines as an emergency measure in preventing epidemic meningitis].
    Xu CH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Dec 29; 3(6):328-30. PubMed ID: 6821030
    [No Abstract] [Full Text] [Related]

  • 17. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
    Ortega-Sanchez IR, Meltzer MI, Shepard C, Zell E, Messonnier ML, Bilukha O, Zhang X, Stephens DS, Messonnier NE, Active Bacterial Core Surveillance Team.
    Clin Infect Dis; 2008 Jan 01; 46(1):1-13. PubMed ID: 18171206
    [Abstract] [Full Text] [Related]

  • 18. A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria.
    Wahdan MH, Sallam SA, Hassan MN, Abdel Gawad A, Rakha AS, Sippel JE, Hablas R, Sanborn WR, Kassem NM, Riad SM, Cvjetanović B.
    Bull World Health Organ; 1977 Jan 01; 55(6):645-51. PubMed ID: 413639
    [Abstract] [Full Text] [Related]

  • 19. [Evolution of meningococcal infection among infant population in the autonomous community of Valencia (1996-2000). Effectiveness of A+C meningococcal vaccination].
    Goicoechea Sáez M, Fullana Montoro AM, Momparler Carrasco P, Redondo Gallego MJ, Brines Solanes J, Bueno Cañigral FJ.
    Rev Esp Salud Publica; 2003 Jan 01; 77(1):125-42. PubMed ID: 12696392
    [Abstract] [Full Text] [Related]

  • 20. Impact of previous immunisation on the incidence of meningococcal disease during an outbreak in a Sahelian area of Senegal.
    Chippaux JP, Diallo A, Marra A, Etard JF.
    Vaccine; 2007 Feb 26; 25(10):1712-8. PubMed ID: 17240492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.